MIAMI, Nov. 28, 2018 (GLOBE NEWSWIRE) — Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced that it has entered into a letter of intent to purchase a Florida based pharmacy with 2 operating locations.
On November 27, 2018, Progressive Care executed a letter of intent to purchase a Florida based pharmacy with locations in Davie and Orlando, Florida. The target pharmacy had just under $16 million in revenue in 2017 and is projected to have approximately $18 million for 2018. The agreement calls for a stratified payment structure for the total purchase price of $3,000,000. $2.3 million in cash spread over 2 years and $700,000 in stock valued at market price at closing or $0.07, whichever is lower. The signing is expected to take place no later than January 15, 2019 after the completion of a 45-day due diligence period.
“We have devoted our efforts to grow the company and expand its geographical coverage,” said S. Parikh Mars, Chief Executive Officer of Progressive Care Inc. “This LOI is a significant step towards our development and presence in the industry. We are excited to add another pharmacy with its exceptional team to our family and platform.”
The vast majority of the target pharmacy’s patient base is in Orlando, and they provide similar services to PharmCo such as home delivery, MTM, medication synchronization, full range inventory, etc. The target pharmacy is owned and managed by an experienced team of pharmacists and operational staff that provide expertise in healthcare management and logistics.
Upon signing of definitive agreements, the Company will initiate the Change of Ownership process with relevant regulatory agencies and pharmacy benefit managers. Upon completion of this process, the target pharmacy will be the wholly owned subsidiary of Progressive Care.
For more information about Progressive Care, please visit the company’s website.
Connect and stay in touch with us on social media:
About Progressive Care Inc.
Progressive Care Inc. (OTCQB: RXMD), through its PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long term care facilities, and health practice risk management.
Cautionary Statement Regarding Forward Looking Statements
Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company’s actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.
Investor Relations Contact:
Armen Karapetyan, Progressive Care
Senior Advisor Business Development
Public Relations Contact:
Kathleen Gonzales, CMW Media
Web and Application Development Contact:
Marcello Jaspan, Mass Ventures Corp